A Living Tradition of the Americas
On May 4, 1953, in a house in West Hollywood, a tall, nearly blind English novelist swallowed four-tenths of a gram of mescaline dissolved in water and sat down in his garden to see what would happen. What happened — described six months later in The Doors of Perception, one of the most influential short books of the twentieth century — was that Aldous Huxley looked at a vase of flowers and saw, for the first time in his life, what the mystics of every tradition had been trying to describe: the "is-ness" of things, the divine radiance of ordinary existence, the suchness that Meister Eckhart called Istigkeit and the Zen masters called tathata. "I was seeing what Adam had seen on the morning of his creation," Huxley wrote, "— the miracle, moment by moment, of naked existence."
Huxley did not invent the idea that psychoactive substances could produce mystical states. Indigenous peoples on every inhabited continent had been using plant medicines for millennia — peyote in Mexico, ayahuasca in the Amazon, psilocybin mushrooms across Mesoamerica, iboga in Central Africa, soma in Vedic India. What Huxley did was translate the experience into the language of Western philosophy and comparative mysticism, and in doing so he opened a door that Western civilisation has been unable to close. The question his book posed — is the mystical experience produced by a chemical substance "real"? — became the central question of what would grow into a tradition encompassing millions of practitioners, thousands of researchers, hundreds of churches, and a fundamental challenge to the materialist assumption that consciousness is reducible to biochemistry. The tradition has been called many things: psychedelic spirituality, entheogenic religion, the medicine path, the psychedelic renaissance. Its practitioners call the substances entheogens — from the Greek entheos, "the god within" — and the name carries their answer to Huxley's question: the experience is real because the god it reveals was always there.
I. The Naming — Psychedelic, Entheogenic, Sacramental
The naming matters, because the name carries the worldview.
Psychedelic — from the Greek ψυχή (psyche, mind/soul) and δηλοῦν (deloun, to manifest) — was coined by the British psychiatrist Humphry Osmond in 1957, in a letter to Huxley. Osmond proposed the word to replace the clinical term "psychotomimetic" (mimicking psychosis), which had framed the experience as pathological. "Psychedelic" — mind-manifesting — was neutral, descriptive, and free of medical stigma. Huxley had proposed "phanerothyme" (making the spirit visible), but Osmond's coinage prevailed. It became the word of the 1960s counterculture — and, because of that association, the word that the subsequent decades of prohibition contaminated with connotations of recklessness, illegality, and countercultural excess.
Entheogen — from the Greek ἔνθεος (entheos, full of the god, inspired) and γενέσθαι (genesthai, to come into being) — was proposed in 1979 by a group of scholars including R. Gordon Wasson, Carl Ruck, Jonathan Ott, and Danny Staples, specifically to describe substances used in a religious or spiritual context. The term was an intentional correction: where "psychedelic" described a psychological effect (the mind is made manifest), "entheogen" described a theological event (the god comes into being within the practitioner). The choice of word is the choice of framework: to call psilocybin a psychedelic is to place the experience in the domain of psychology; to call it an entheogen is to place it in the domain of religion.
Sacrament is the word used by the tradition's most explicitly religious practitioners — those who regard the substances not as tools for exploring consciousness but as vehicles of divine communion. The analogy to the Eucharist is deliberate: as the bread and wine of the Christian Mass are understood by believers to be (or to become) the body and blood of Christ, so the peyote, the ayahuasca, the psilocybin mushroom are understood by entheogenic practitioners to be vehicles of direct encounter with the sacred. The legal significance of this framing is considerable: the US Supreme Court's recognition of peyote as a sacrament of the Native American Church (1994) and ayahuasca as a sacrament of the União do Vegetal (2006) established that entheogenic use in a genuine religious context is protected by the First Amendment.
II. The Precursors — Indigenous Traditions and the Western Encounter
The entheogenic tradition in the Americas is not a twentieth-century invention. It is a twentieth-century rediscovery of practices that indigenous peoples had maintained for thousands of years.
Peyote (Lophophora williamsii) — the small, spineless cactus containing mescaline — has been used ritually in present-day Mexico for at least 5,700 years, based on radiocarbon dating of peyote specimens found in archaeological sites in the Rio Grande region. The Huichol (Wixárika) people of the Sierra Madre Occidental maintain an unbroken peyote tradition centred on annual pilgrimages to Wirikuta, the desert homeland of the peyote. The Native American Church (NAC), founded formally in 1918 but drawing on centuries of pan-tribal peyote use, combines peyote ceremony with Christian prayer and represents the most successful indigenous-entheogenic synthesis in North America.
Psilocybin mushrooms — Psilocybe mexicana, P. cubensis, and related species — were used throughout Mesoamerica. The Aztecs called them teonanácatl, "flesh of the gods." Spanish colonial authorities suppressed the practice as demonic, and it survived only in remote indigenous communities — until 1955, when the American banker and amateur mycologist R. Gordon Wasson participated in a velada (mushroom ceremony) led by the Mazatec curandera María Sabina in Huautla de Jiménez, Oaxaca. Wasson's account, published in Life magazine in 1957, introduced psilocybin mushrooms to the Western public — and, in an act of cultural impact that Wasson later regretted, brought a flood of Western seekers to Huautla that disrupted María Sabina's life and community.
Ayahuasca — the brew made from Banisteriopsis caapi vine and Psychotria viridis leaves, containing DMT and MAO inhibitors — has been used by indigenous groups across the western Amazon basin for at least a thousand years. The three major ayahuasca churches — Santo Daime (founded 1930), Barquinha (founded 1945), and União do Vegetal (founded 1961) — are Brazilian syncretic religions that combine ayahuasca ceremony with Christian theology and are profiled separately in this archive.
Iboga (Tabernanthe iboga) — the root bark used in the Bwiti initiation ceremonies of Gabon and Cameroon, containing the psychoactive alkaloid ibogaine — represents the African expression of the entheogenic tradition. Bwiti is profiled separately in this archive.
The Western entheogenic tradition's relationship with these indigenous practices is a source of both inspiration and ethical complication. Every significant development in the Western tradition — Huxley's mescaline experience, Wasson's mushroom ceremony, the ayahuasca tourism industry — ultimately derives from indigenous knowledge. The tradition's debt to indigenous peoples is immense, and its record of honouring that debt is, at best, mixed.
III. The Prophets — Huxley, Leary, and the Divergent Paths
The Western entheogenic tradition was shaped by two figures whose approaches were so different that they created, in effect, two separate lineages: the path of quiet transformation and the path of public evangelism.
Aldous Huxley (1894–1963) represented the contemplative path. His The Doors of Perception (1954) and its sequel Heaven and Hell (1956) argued that mescaline and similar substances functioned as what he called a "reducing valve" — temporarily bypassing the brain's filtering mechanisms to allow consciousness to perceive reality as it actually is, in its overwhelming fullness. Huxley's framework was scholarly, comparative, and cautious: he drew parallels between psychedelic experience and the mystical traditions of every culture, insisted that the substances were tools for serious spiritual investigation rather than recreational amusement, and warned that widespread unsupervised use would invite a backlash that would make the substances inaccessible to everyone. He advocated for controlled, private, carefully guided experiences among a relatively small number of serious seekers.
Timothy Leary (1920–1996) represented the evangelical path. A Harvard psychologist who first took psilocybin in Cuernavaca, Mexico, in 1960, Leary became convinced that psychedelics could transform not just individual consciousness but civilisation itself. With his colleague Richard Alpert (later Ram Dass), Leary conducted the Harvard Psilocybin Project (1960–1963), administering psilocybin to graduate students, prisoners, and divinity students in experiments that produced both remarkable results (the Marsh Chapel Experiment of 1962, in which divinity students given psilocybin during a Good Friday service reported genuine mystical experiences at a rate indistinguishable from those of classical mystics) and significant controversy (the experiments' lack of controls, Leary and Alpert's increasingly visible personal use, and the general perception that the researchers had gone native). Both were dismissed from Harvard in 1963.
Leary's subsequent career — the Millbrook commune, the "Turn on, tune in, drop out" slogan, the League for Spiritual Discovery, the arrests, the prison escape, the exile, the return — became the public face of psychedelic culture and, in the minds of mainstream America, confirmed every fear about psychedelics that Huxley had warned against. Nixon called Leary "the most dangerous man in America." The resulting backlash — the criminalisation of LSD in 1966, psilocybin and mescaline under the Controlled Substances Act of 1970 — shut down not only recreational use but virtually all scientific research for three decades.
Ram Dass (1931–2019) — Richard Alpert transformed — represented a third path. After his dismissal from Harvard, Alpert travelled to India, where he met the guru Neem Karoli Baba (Maharaj-ji), who, according to Alpert's account, took a massive dose of LSD with no observable effect — demonstrating that the states psychedelics produced were available through other means. Alpert returned to America as Ram Dass ("servant of God"), published Be Here Now (1971), and spent the rest of his life teaching meditation, devotion, and service — acknowledging that psychedelics had opened the door but insisting that the door could be entered by other means. His path represented the integration of entheogenic experience into a broader spiritual practice, rather than the perpetual return to the substance itself.
Huxley's prophecy proved accurate. The evangelical path produced a backlash that closed the door for decades. The contemplative path — the one that continued underground, in therapeutic settings, in careful private practice — was the one that eventually reopened it.
IV. The Underground Decades — 1970–2000
The criminalisation of psychedelics did not end their use. It ended their visibility.
For three decades — from the passage of the Controlled Substances Act in 1970 to the beginning of the psychedelic renaissance around 2000 — the entheogenic tradition survived underground: in private ceremonies, in unregulated therapeutic practices, in the ayahuasca churches of Brazil, in the peyote ceremonies of the Native American Church, in the Grateful Dead parking lot, in the rave scene, and in a network of quiet, serious practitioners who continued to use psychedelics as spiritual tools while the culture around them criminalised, stigmatised, and forgot.
Stanislav Grof (1931–2024) was the most important figure of the underground decades. A Czech-born psychiatrist who had conducted LSD-assisted psychotherapy at the Psychiatric Research Institute in Prague and later at Spring Grove Hospital in Maryland (one of the last legal LSD research programmes in the United States), Grof had personally conducted or supervised over four thousand LSD sessions before the substance was criminalised. His books — Realms of the Human Unconscious (1975), The Adventure of Self-Discovery (1988), The Cosmic Game (1998) — constituted the most comprehensive attempt to map the phenomenology of psychedelic experience in psychological and spiritual terms.
Grof's cartography of consciousness described four levels of psychedelic experience: the sensory/aesthetic (enhanced perception of colour, form, and beauty), the biographical/psychodynamic (the reliving of personal memories, especially birth trauma, which Grof called "basic perinatal matrices"), the perinatal (the experience of death and rebirth, structured by the stages of biological birth), and the transpersonal (experiences that transcend individual identity — past-life memories, identification with other beings, encounters with archetypal figures, cosmic consciousness, the Void). The transpersonal level was, in Grof's view, the genuinely revolutionary dimension: evidence that consciousness is not produced by the brain but is a fundamental feature of the cosmos that the brain normally filters.
When LSD was criminalised, Grof developed holotropic breathwork — a technique using rapid, rhythmic breathing, evocative music, and focused bodywork to induce non-ordinary states of consciousness comparable to those produced by psychedelics. Holotropic breathwork became the bridge between the psychedelic era and the renaissance: it kept the tradition's phenomenology alive in a legal form, trained thousands of practitioners in the navigation of non-ordinary states, and demonstrated that the experiences psychedelics produced were not mere pharmacological artifacts but genuine capacities of the human mind.
Alexander "Sasha" Shulgin (1925–2014) and his wife Ann Shulgin (1931–2022) maintained the alchemical tradition through the underground decades. A chemist who had previously worked for Dow Chemical, Shulgin synthesised and bioassayed over 230 psychoactive compounds in his home laboratory in Lafayette, California, documenting the results in two extraordinary books: PiHKAL: A Chemical Love Story (1991, covering phenethylamines) and TiHKAL: The Continuation (1997, covering tryptamines). The books combined rigorous chemistry, first-person phenomenological reports, and a love story between the Shulgins themselves. They were, in effect, the entheogenic tradition's pharmacopoeia — a Materia Medica for the soul.
Terence McKenna (1946–2000) was the underground decades' most charismatic public voice. An ethnobotanist, psychonaut, and electrifying public speaker, McKenna advocated for psilocybin mushrooms as humanity's most important sacrament and developed increasingly speculative theories about the role of psychedelics in human evolution (the "stoned ape" hypothesis) and in the structure of time itself (the "Timewave Zero" theory, which predicted a singularity of novelty in December 2012 — a prediction that did not materialise). McKenna's lectures — circulated on cassette tapes, CDs, and later YouTube — kept the entheogenic vision alive for a generation of seekers who had no other access to it.
V. The Renaissance — From Johns Hopkins to Oregon
The psychedelic renaissance — the return of psychedelic research to mainstream science and, eventually, to legal therapeutic and religious use — began slowly in the 1990s and accelerated dramatically in the 2010s and 2020s.
Rick Doblin (b. 1953), the founder of the Multidisciplinary Association for Psychedelic Studies (MAPS, founded 1986), spent three decades navigating the regulatory labyrinth of the US Food and Drug Administration and the Drug Enforcement Administration to bring psychedelic-assisted therapy back into clinical trials. MAPS's Phase III trials of MDMA-assisted therapy for post-traumatic stress disorder (PTSD) — which showed remission rates of 67 percent after three sessions, compared to 32 percent for therapy alone — were the most clinically significant results in the history of psychedelic research. Although the FDA declined to approve MDMA-assisted therapy in August 2024, citing methodological concerns, the trials had demonstrated to the mainstream medical community that psychedelic therapy was not countercultural fantasy but serious clinical medicine.
Roland Griffiths (1946–2023) and his team at Johns Hopkins University published a landmark 2006 study — "Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance" — that reignited academic interest in the spiritual dimensions of psychedelic experience. Griffiths's research was methodologically rigorous, emotionally sensitive, and startling in its conclusions: a single high-dose psilocybin session, conducted in a supportive setting with trained guides, produced experiences that participants rated as among the most meaningful and spiritually significant of their lives — and the effects persisted at fourteen-month follow-up. Griffiths's later studies explored psilocybin's potential for treating depression, addiction, and end-of-life distress in terminal cancer patients, with consistently remarkable results.
The Johns Hopkins Center for Psychedelic and Consciousness Research (established 2019) — the first psychedelic research centre at a major American university since the 1960s — was followed by similar centres at NYU, Imperial College London, the University of California Berkeley, and dozens of other institutions. By the mid-2020s, psychedelic research was one of the most active and well-funded fields in psychiatry and neuroscience.
The legal landscape shifted in parallel. Oregon's Measure 109 (2020) created the first state-regulated psilocybin therapy programme in the United States, allowing adults to receive psilocybin in licensed "service centres" under the guidance of trained facilitators. Colorado's Proposition 122 (2022) decriminalised psilocybin and several other psychedelic substances and established a regulatory framework for therapeutic use. More than a dozen American cities — including Denver, Oakland, Seattle, Ann Arbor, and Washington, D.C. — passed local decriminalisation measures. The trajectory toward broader legal access, while contested and far from complete, appeared by the mid-2020s to be irreversible.
VI. The Churches — Entheogenic Religion in America
The entheogenic tradition's most explicitly religious expression is the growing number of psychedelic churches — organisations that claim the sacramental use of psychedelic substances as a protected religious practice under the First Amendment and the Religious Freedom Restoration Act (RFRA).
The legal precedent was established by two Supreme Court cases. Employment Division v. Smith (1990) ruled that generally applicable drug laws could be applied to religious practitioners — effectively ending the protection that the Native American Church's peyote use had enjoyed under lower court rulings. The Religious Freedom Restoration Act (1993) — passed by Congress in response to Smith — restored the "compelling interest" test, requiring the government to demonstrate a compelling state interest before burdening religious exercise. Gonzales v. O Centro Espírita Beneficente União do Vegetal (2006) applied RFRA to ayahuasca, ruling unanimously that the government had not demonstrated a compelling interest in prohibiting the UDV's sacramental use of the brew.
These precedents opened the door to a new generation of entheogenic churches. The Church of the Eagle and the Condor, the Soul Quest Ayahuasca Church of Mother Earth, the Oratory of Mystical Sacraments, and dozens of smaller organisations have claimed RFRA protection for ayahuasca, psilocybin, or other psychedelic sacraments. The legal landscape is treacherous: DEA enforcement actions against some churches and tolerance of others have created an inconsistent patchwork, and the question of what constitutes a "sincere religious belief" (as opposed to a legal convenience) remains hotly contested.
The most theologically developed of the new entheogenic churches draw explicitly on the tradition's intellectual lineage. They cite Huxley and Grof, Wasson and McKenna. They frame the psychedelic experience in the language of mysticism, comparative religion, and transpersonal psychology. They develop liturgies, train facilitators, maintain codes of ethics, and provide integration support (structured follow-up to help participants incorporate their experiences into daily life). They represent the entheogenic tradition's attempt to become what its most thoughtful advocates have always claimed it could be: not a recreational subculture, not a clinical intervention, but a genuine religious tradition with its own sacraments, its own cosmology, its own priesthood, and its own understanding of the sacred.
VII. The Experience — What the Medicine Shows
The entheogenic tradition's central claim is experiential, not doctrinal: that certain substances, taken in the right setting with the right preparation and the right intention, produce experiences of genuine spiritual significance. The tradition cannot be understood without some account of what those experiences are.
The Griffiths criteria for "mystical-type experience," developed from Walter Stace's philosophical analysis and validated through the Johns Hopkins research programme, identify seven core features: unity (the experience of becoming one with all things, the dissolution of the boundary between self and world); noetic quality (the conviction that what is being experienced is not a hallucination but a direct apprehension of reality — more real than ordinary experience, not less); sacredness (the sense of encountering the holy, the numinous, the divine); positive mood (feelings of awe, reverence, gratitude, and ecstatic joy); transcendence of time and space (the sense that ordinary spatial and temporal coordinates have dissolved); ineffability (the conviction that the experience cannot be adequately described in words); and paradoxicality (the experience of truths that violate the logic of ordinary consciousness — that everything is one and simultaneously infinitely diverse, that the self both exists and does not exist, that death is real and simultaneously an illusion).
These criteria correspond closely to the features of mystical experience described in the world's contemplative traditions. William James identified them in 1902 (The Varieties of Religious Experience). Evelyn Underhill mapped them in 1911 (Mysticism). Rudolf Otto named the mysterium tremendum et fascinans in 1917 (The Idea of the Holy). The entheogenic tradition's claim is not that psychedelics produce a new kind of experience but that they provide reliable access to an experience that every mystical tradition has described and that is otherwise available only to the few who achieve it through decades of contemplative practice, or to those upon whom it descends unsought as grace.
The implications of this claim are staggering. If a chemical substance can reliably produce genuine mystical experience, then either mystical experience is "merely" neurochemical (and the traditions that revere it are deluded) or the brain is not the producer of consciousness but a receiver — a reducing valve, in Huxley's metaphor, that normally restricts consciousness to the narrow band necessary for biological survival and that psychedelics temporarily open to a wider spectrum. The entheogenic tradition has consistently argued for the second interpretation. The neuroscientific evidence — particularly the finding that psilocybin decreases activity in the brain's default mode network (the region associated with the sense of self) rather than increasing overall brain activity — is at least consistent with the "reducing valve" hypothesis, though it does not prove it.
VIII. The Ethics — Set, Setting, and the Problem of Access
The entheogenic tradition has developed, through painful experience, a sophisticated understanding of the conditions under which psychedelic substances can be used safely and beneficially — and the conditions under which they can cause harm.
Set (the internal psychological state of the person taking the substance — their expectations, fears, intentions, mental health, current emotional state) and setting (the external environment — the physical space, the people present, the music, the lighting, the availability of trained support) are the tradition's two master variables. The same substance, at the same dose, can produce transcendent mystical experience in one set and setting and terrifying psychological crisis in another. The tradition's insistence on the importance of set and setting is its most practically important teaching and the one most consistently validated by clinical research.
Preparation (establishing intention, building trust with guides, clearing the psychological ground) and integration (the structured process of making sense of the experience after it ends, incorporating its insights into daily life, and addressing any difficult material that emerged) are the bookends that distinguish sacramental use from recreational use. The experience itself, however profound, is only the seed. Integration is the soil.
The tradition's most serious ethical challenges include:
The access problem. Oregon's regulated psilocybin therapy, the first legal programme in the United States, costs between $1,500 and $3,500 per session — a price that excludes the vast majority of the people who might benefit. The clinical trial model, while scientifically necessary, produces therapies that are accessible primarily to the educated, insured, and affluent. The entheogenic tradition's indigenous sources — peyote, ayahuasca, mushrooms — were traditionally available to entire communities, not just those who could pay. The commodification of psychedelic therapy is a live and contentious issue within the tradition.
The guru problem. The tradition has produced its share of sexual predators, narcissists, and authoritarian personalities who exploit the vulnerability that psychedelic states create. The cases are too numerous and too serious to list comprehensively. The tradition's response — facilitator ethics training, peer accountability structures, consent protocols, codes of conduct — is a work in progress.
The appropriation problem. The entheogenic tradition's debt to indigenous peoples is immeasurable. Ayahuasca was not "discovered" by Westerners; it was shared, often without full consent and without equitable return. The extraction of indigenous knowledge by the psychedelic industry — without adequate compensation, without meaningful indigenous participation in governance, and without respect for the cultural and spiritual contexts in which these medicines originated — is the tradition's deepest ethical wound.
The sustainability problem. Peyote — slow-growing, restricted in range, subject to habitat loss — is in conservation crisis. The Wixárika people and the Native American Church have asked non-indigenous users to stop using wild-harvested peyote. The mescaline synthesis available since the nineteenth century offers a chemical alternative, but the tradition's emphasis on the plant as a living being (rather than a delivery system for a molecule) makes the substitution philosophically fraught. Sustainable cultivation programmes for psilocybin mushrooms are well-established. Ayahuasca sustainability depends on the management of Banisteriopsis caapi vine, which is not yet in crisis but could become so as demand grows.
IX. The Current State — Between Medicine and Religion
The entheogenic tradition in the mid-2020s stands at an extraordinary inflection point.
The clinical path — psilocybin for depression, MDMA for PTSD, ketamine for treatment-resistant depression (already FDA-approved as esketamine/Spravato) — is advancing rapidly through the regulatory framework. The clinical evidence is strong, the investment capital is flowing (psychedelic biotech companies raised over $2.5 billion between 2019 and 2023), and the public acceptance of "psychedelic-assisted therapy" has shifted from countercultural fringe to mainstream consideration.
The religious path — the claim that psychedelic substances are sacraments deserving First Amendment protection — is advancing through the courts, with the UDV and NAC precedents providing the constitutional framework and a growing number of new churches testing its limits.
The decriminalisation path — the city-by-city and state-by-state reduction of criminal penalties for possession and use of psychedelic substances — is advancing through the ballot initiative process, driven by the same grassroots organising model that succeeded for cannabis.
These three paths are not always compatible. The clinical path medicalises the experience (the "patient" receives a "treatment" in a "clinic"). The religious path sacralises it (the "communicant" receives a "sacrament" in a "ceremony"). The decriminalisation path normalises it (the "adult" makes a "choice" in "private"). Each path has its own advocates, its own institutional structures, and its own relationship to the tradition's deeper claims about the nature of consciousness and the reality of mystical experience.
The tradition's deepest thinkers — from Huxley through Grof to the current generation — have consistently argued that the medical and religious paths are not ultimately in conflict, because the psychedelic experience itself dissolves the categories that separate them. Healing and awakening are the same event. The remission of PTSD symptoms and the encounter with the sacred are aspects of the same transformation. The tradition's most radical claim — that consciousness is fundamental, that the brain is a receiver rather than a generator, and that psychedelics open the valve — applies equally to the clinical and the ceremonial context.
Whether mainstream Western civilisation will be able to integrate this claim, or whether the medical model will domesticate it into a pharmacological tool stripped of its spiritual dimensions, is the question the tradition is currently living. The door that Huxley opened in 1953 is open wider now than it has been at any point in the seven decades since. What comes through it — wisdom or commerce, liberation or commodification, or some characteristically American mixture of both — remains to be seen.
Colophon
The entheogenic tradition is the spiritual movement that holds psychedelic substances to be sacraments capable of producing genuine mystical experience — a tradition whose roots extend through the indigenous plant-medicine practices of every inhabited continent and whose Western expression runs from Aldous Huxley's mescaline revelation in 1953 through the counterculture, the underground decades, and the twenty-first-century psychedelic renaissance. It is currently the fastest-growing edge of American spirituality, manifesting simultaneously as clinical therapy, religious practice, and political movement. Its central claim — that consciousness is fundamental and that certain substances provide reliable access to its deeper dimensions — is the most radical challenge to materialist assumptions in contemporary Western culture.
Compiled and formatted for the Good Work Library by the New Tianmu Anglican Church, 2026. Researched and written by Mizu, Aquarian Scout of the Living Traditions lineage.
🌲